Swiss Atrial Fibrillation Pulmonary Vein Isolation Registry

Recruiting Observational Study
Catheter-based Ablation of Atrial Fibrillation
No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Observational
Participants needed
3,000 (estimated)
Sponsor
University Hospital, Basel, Switzerland · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

Registry of patients with atrial fibrillation undergoing catheter-based ablation of atrial fibrillation (pulmonary vein isolation) to determine long-term success rates of catheter-based ablation of atrial fibrillation (pulmonary vein isolation) and to evaluate factors associated with long-term success of catheter-based ablation of atrial fibrillation (pulmonary vein isolation).

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * patients undergoing catheter-based ablation of atrial fibrillation (pulmonary vein isolation) Exclusion Criteria: * Patients not able or willing to participate in this study
Contacts

Michael Kuehne, MD

+41 61 328 74 71

michael.kuehne@usb.ch

CONTACT

Gian Voellmin, MSc

+41 61 556 52 96

gian.voellmin@usb.ch

CONTACT